MedPath

Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment

Not Applicable
Completed
Conditions
Traumatic Brain Injury
Mild Cognitive Impairment
Interventions
Behavioral: Placebo Control
Behavioral: Speed of Processing Training
Registration Number
NCT02020564
Lead Sponsor
Kessler Foundation
Brief Summary

The purpose of this research study is to investigate the effectiveness of a technique designed to improve processing speed (i.e. the amount of time it takes to process information) in a Traumatic Brain Injury (TBI) population. The study is designed to study how well this technique can help people with TBI increase their processing speed and their ability to function better in everyday life.

Detailed Description

The current proposal is designed to apply this treatment protocol to a large sample of individuals with moderate to severe TBI with documented impairment in PS. The goals of the trial are to (a) test the efficacy of this treatment protocol within a TBI population, (b) evaluate the impact of the treatment on everyday functioning, (c) evaluate the longer-term efficacy of the treatment, and (d) examine the utility of booster sessions in facilitating longer-term treatment effects. Individuals with moderate to severe TBI, with documented impairment in PS, will be randomly assigned to a treatment group or a control group. Both groups will undergo baseline, immediate post-treatment and long-term follow-up assessment consisting of: (1) a standardized neuropsychological battery and (2) an assessment of global functioning examining the impact of the treatment on daily activities. This design will allow us to assess the efficacy of SPT in persons with TBI and evaluate its impact on everyday life.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • diagnosis of Traumatic Brain Injury or Mild cognitive impairment
  • Fluent in English
  • processing speed impairment
Exclusion Criteria
  • prior stroke or neurological disease
  • currently taking steroids and/or benzodiazepines
  • history of significant pyschiatric illness (for example, bipolar disorder, schizophrenia, or pyschosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Epilepsy, Bipolar Disorder
  • significant alcohol or drug abuse history

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo control groupPlacebo ControlComputerized exercises will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).
Treatment GroupSpeed of Processing TrainingComputerized exercised will be administered on a laptop computer twice a week for 5 weeks (10 training sessions).
Primary Outcome Measures
NameTimeMethod
Symbol-Digit Modalities TestBaseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention

Change in scores on standardized neuropsychological tests of Processing Speed using Symbol-Digit Modalities Test

Secondary Outcome Measures
NameTimeMethod
TBI Quality of Life, Total ScoreBaseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention

Change in scores on self-report of quality of life, measured via questionnaire. DV is the TBI-QOL total score. The range is 1-40. A higher score indicates better quality of life.

TBI Quality of Life, Depression scaleBaseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention

Change in scores on self-report of emotional functioning, measured via questionnaire. The TBI QOL Depression scale measures depression. The range is 1-40. A higher score indicates greater depression.

Perceived Deficits QuestionnaireBaseline (week 1), immediately post-intervention (week 7) and 3 months post-intervention

Change in scores on self-report of perceived cognitive deficits in daily life, measured via questionnaire. A higher score indicates greater perceived deficits in daily life. Range of scores on the scale is 0-80.

Trial Locations

Locations (1)

Kessler Foundation

🇺🇸

East Hanover, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath